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Abstract: This study was carried out to determine the seroprevalence of hepatitis D virus among HBsAg 
positive individuals in the northeast part of Iran. One hundred thirty nine HBsAg positive subjects detected 
from a population based single stage cluster sampling in Golestan province of Iran were enrolled. All cases were 
evaluated for the presence of anti-HDV antibodies using commercially available ELISA kits. Logistic regression 
was used to determine the relationship between independent variables and HDV seropositivity. Of 139 cases, 
68( 48.9%)weremales and 71(51.1 %)were females. The mean age was 41.89±1 l .30years (25-64 years). Anti-HDV 
antibody was positive in 8 (5.8%) subjects with female predominance (9.9% versus 1.5%, p = 0.06; odds 
ratio= 7.32, 95%CI: 0.87-61.23). No significant relationship was seen between anti-HDV seropositivity and 
demographic factors such as age, place of residence and marital status. These findings showed that HDV 
infection was endemic in Golestan province (northeast) of Iran. Seroprevalence of Anti-HDV in the present 
study was higher than some previous studies from other parts of Iran. Our results suggest that the prevalence 
of HBV/HDV co-infection in Iran has increased during the last decade. Therefore, practitioners and all health 
care managers should be made aware of the risk of dual infection with HBV and HDV. 
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INTRODUCTION 	
Hepatitis B Virus (HBV) infection is one of the most 
prevalent public health problems worldwide (especially in 
developing countries). It causes 1 million deaths annually 
(Zaki et al., 2003). More than 3% of Iranian populations 
are involved with HBV infection (Massarat et al., 2000; 
Hasanjani Roshan and Taheri, 2002). 
Hepatitis D Virus (HDV) is a defective RNA virus 
dependent on hepatitis B Virus (HBV) infection for its 
replication and expression (Jacobson et al., 1995; 
Kawal andFeinstone, 2000). HDV is well knovvn to induce 
a spectrum of acute and chronic liver diseases. More than 
15 million patients are infected with HDV and its 
prevalence in Italy, east of Europe and west of Asia is 
higher than the rest of the world (Gaeta et al., 2000; 
Ivaniushina et al., 1996). Its infection appears to be 
endemic in the Middle East (Tapalaga et al., 1986). 
Infection with HDV can occur simultaneously with acute 
HBV infection or may be superimposed on chronic HBV 
infection (Chakraborty et al., 2005). It is known that 
co-existent infection with HDV tends to accelerate the 
progress of chronic HBV infection to chronic hepatitis, 
cirrhosis and hepatocellular carcinoma (T oukan and 
al-Khanderi, 1991; Dienstag and Isselbacher, 1998). 
Fulminant hepatitis may develop in 20-30% of 
patients co-infected with both HBV and HDV but only 2% 
of patients infected with isolated HBV might experience 
such complication (Kawal and Feinstone, 2000). 
This study carried out to determine the 
seroprevalence of hepatitis D virus among HBsAg 
positive individuals 1n the Golestan Province 
(northeast part) oflran. 
MATERIALS AND METHODS 
A population based cross-sectional study had been 
conducted in Golestan province of Iran during 2004 to 
2005. A total sample size of 1850 subjects had been 
enrolled using a single stage cluster sampling method. To 
achieving this sample, 92 clusters had been selected using 
a systemic random sampling according to last census tract 
in Golestan province of Iran (2004-2005). In each cluster, 
20 subjects had been explored for hepatitis B virus surface 
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antigen using ELISA kit, Diasorin, Italy (Sensitivity: 
100%; Specificity: 98.8% ). 164 (8.9%) ofl 850 subjects had 
been positive for HBsAg. Unfortunately, the serum 
samples of 25 HBsAg positive subjects were inadequate 
or had been lost during the sampling phase. Therefore, 
139 of the HBsAg positive subjects were enrolled in our 
study. Approximately 2 mL blood sample was collected 
from each subject. Separation of serum was done llllder 
complete aseptic conditions and then stored at -70°C until 
use. The serological test was performed usmg 
commercially available ELISA method according to the 
instructions provided in the manufacturers' manual. Anti­
HDV antibody was detected using ELISA kit, Radim, 
England (Sensitivity: >98%; Specificity: >98%). All data 
were analyzed by SPSS (Chicago, IL) software, version 12 
and STATA version 8. Proportions were compared by 
Chi-square and Fisher's exact tests. Logistic regression 
was used to determine the relationship between 
independent variables and HDV seropositivity. p-values 
of less than 0.05 were considered significant. Variables 
with p-values of less than 0.1 were analyzed by 
multivariable logistic regression. Model fitness was 
assessed by Hosmer-Lemeshow statistics. 
RESULTS 
Of the 139 cases, 68 (48.9%) were males and 71 
(51.1 %) were females. The mean age was 41.89±11.30 
years (25-64 years). Demographic characteristics of the 
subjects are summarized in Table 1. Of the 139 cases, eight 
were found to be reactive for anti-HDV antibodies, 
yielding an overall HDV seroprevalence of 5.8% (95% CI: 
2.5-11.0%). Anti-HDV antibody was positive in seven (9.9, 
95 CI: 4.1-19.3%) offemales and me (1.5, 95 CI: 0.04-7.9%) 
of males, but the difference was not statistically 
significant (p~0.06) (Table 2). The prevalence of HDV 
seropositivity in rural population was higher than 
urban population (7.5% versus 4.7%, respectively), 
Table 1: Demographic characteristics of the shJdied subjects 
Variables No. of cases (%2" 
Sex Male 68 (48.9) 
Female 71 (51.1) 
Age groupsfyears) <30 32 (23) 
30-50 65 (46.8) 
<50 42 (30.2) 
Marital stalls Married 119 (85.6) 
Single 20(14.4) 
Body mass index <25 53 (38.1) 
(B11I) groups 25-29.9 49 (35.3) 
(kgm-2) 30-34.9 22 (15.8) 
,35 15 (10.8) 
Place of residence Urban area 86(61.9) 
Rural area 52 (38.10) 
"Missing data were deleted 
although no significant relationship was seen (p = 0.48). 
Seroprevalence of hepatitis D virus did not significantly 
differ between age groups. Ten percent of singles and 5% 
of married subjects were positive for anti-HDV antibody, 
but the difference was not significant (p ~ 0.38) (Table 2). 
There was a significant relationship between HDV 
seropositivity and subjects' body mass index (BJ'v:lI). 
That means, HDV infection was significantly higher in 
severe obese (BJ'v:lI>35 kg m-2) than reference group 
(BM!<25 kg m-'). But when it was adjusted with sex by 
multivariate logistic regression, no significant relationship 
was found between BM! and HDV positivity (Table 2). 
DISCUSSION 
In present study, we conducted a 
seroepidemiological survey of co-infection with hepatitis 
D virus in 139 apparently healthy HBsAg positive 
individuals living in Golestan province (northeast part) of 
Iran. The seroprevalence of anti-HDV antibody in our 
study was 5.8% that indicates the endemicity of HDV 
infection in Golestan province (northeast) of Iran. It 
was considerably high, when compared with some 
previous similar Iranian studies (Hasanjani Roshan and 
Taheri, 2002; Rezvan et al., 1990; Amini et al., 1993). 
Rezvan et al. (1990) detected anti-HDV antibodies in 2.5% 
of asymptomatic HBsAg carriers. Amini et al. (1993) had 
reported the same prevalence (2.4%) ofHDV infection in 
similar population from Ramadan. Hasanjani Roshan and 
Taheri (2002) from Babol, Iran had reported HDV 
positivity in 2% of HBV carriers. In contrast with 
these results, HDV seropositivity had been reported as 
6% among HBsAg positive subjects from Tabriz 
(Torabi et al., 2002). Recently, Alavian et al. (2005) have 
reported 5.7% ofHDV seropositivity among HBV infected 
subjects in Iran (Alavian et al., 2005). These results 
suggest that the prevalence of HBV/HDV co-infection in 
Iran has increased during the last decade. In other 
parts of the world, the seroprevalence of HDV among 
HBsAg positive cases was 1.5, 1.6, 2.2, 4, 16.6 and 
24.4% in Yugoslavia (Dellic et al., 1993), Spain 
(de Miguel et al., 1994), Taiwan (Chen and Tseng, 1992), 
Mexico (Munoz Espinosa and Ibarrasalas, 1997), Pakistan 
(Mumtaz et al., 2005) and Bangladesh (Zaki et al., 2003), 
respectively. Analysis of sex-related seroprevalence of 
HDV antibody in our study showed that the females 
(9.9%) were more infected than males (1.5%). This finding 
was not in conformity with earlier reports from Babol, Iran 
(Hasanjani Roshan and Taheri, 2002) and Pakistan 
(Mumtaz et al., 2005). In present study, subjects living in 
rural area showed a higher prevalence of HDV 
seropositivity than urban population. This is consistent 
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Table 2: Relationships between HDV seropositivity and socio-demographic factors in HBsAg subjects 
Variables Crude odds ratio (95% Cl) p-value Adjusted odds ratio (95o/oCD a p-value 
Sex Male 1 
Female 7.32 (0.87-61.23) 0.06 6.24 (0.71-54.55) 0.09 
Age groups <30 1 
(}rears) 30-50 0.63 (0.13-3.02) 0.57 
>50 0.23 (0.2-2.38) 0.22 
Marital stahls Married 1 
Single 2.09 (0.39-11.18) 0.39 
Body mass index <25 1 
(B11I) groups 25-29.9 1.11 (0.15-8.19) 0.92 0.83 (0.11-6.37) 0.86 
(kgm-2) 30-34.9 1.11 (0.09-12.85) 0.93 1.00 (0.08-11.99) 0.10 
=35 8.5 (1.24-58.23) 0.03 5.52 (0.76-40.20) 0.09 
Place of residence Urban area 1 
Rural area 1.67 0.40-6.99 0.48 
" Only variables with p-values <0.1 were analyzed by multivariable logistic regression 
with findings of Mumtaz et al. (2005) from Pakistan. 
Present results showed that the prevalence of anti-HDV 
antibody was higher in yormg and single population. It 
was knovvn that this is due to high-risk behaviors among 
them. Mumtaz et al. (2005) from Pakistan had reported 
similar findings. 
We folllld that HDV infection was significantly 
higher in severe obese (BJ'v:lI>35 kg m-2) than other 
individuals. We did not find this relationship in previous 
studies and no causal relationship had been proposed 
between HDV infection and patient's BJ'v:lI. Therefore, we 
used multivariate logistic regression to detect possible 
confounder effects of other variables. For this reason, we 
adjusted BJ'v:lI with sex (two variables with p-values of less 
than 0.1). After adjustment with multivariate logistic 
regression, no significant relationship was found between 
BM! and HDV positivity (Table 2). In fact, our data 
suggested that relationship between HDV infection and 
sex was more significant than that of BJ'v:lI. However, 
because the power of our study was low ( 41 %), we could 
not find statistically significant relationship between sex 
and HDV seropositivity. So more studies with larger 
sample sizes should be designed to determine this 
association. 
In conclusion, present findings showed that HDV 
infection is endemic in Golestan province (northeast) of 
Iran. Seroprevalence of Anti-HDV in the present study 
was higher than some previous studies from other parts 
of Iran. Present results suggest that the prevalence of 
HBV!HDV co-infection in Iran has increased during the 
last decade. Therefore, practitioners and all health care 
managers should be made aware of the risk of dual 
infection with HBV and HDV. 
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